Kerry E. Laing Kilbridge, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 7 | 2024 | 11103 | 0.380 |
Why?
|
Health Literacy | 3 | 2014 | 443 | 0.380 |
Why?
|
Mobility Limitation | 2 | 2010 | 408 | 0.340 |
Why?
|
Interferon-alpha | 2 | 2002 | 907 | 0.280 |
Why?
|
Survivors | 2 | 2008 | 2369 | 0.280 |
Why?
|
Medically Underserved Area | 1 | 2009 | 254 | 0.270 |
Why?
|
Family Relations | 1 | 2008 | 315 | 0.260 |
Why?
|
Comparative Effectiveness Research | 1 | 2010 | 709 | 0.240 |
Why?
|
Social Support | 3 | 2010 | 2175 | 0.230 |
Why?
|
Disabled Persons | 2 | 2010 | 1226 | 0.230 |
Why?
|
Quality-Adjusted Life Years | 1 | 2010 | 1723 | 0.220 |
Why?
|
Complementary Therapies | 1 | 2007 | 486 | 0.210 |
Why?
|
Activities of Daily Living | 2 | 2010 | 2420 | 0.200 |
Why?
|
Internet | 1 | 2012 | 3094 | 0.170 |
Why?
|
Genetic Counseling | 1 | 2023 | 628 | 0.170 |
Why?
|
Patient Education as Topic | 1 | 2009 | 2316 | 0.160 |
Why?
|
Educational Status | 4 | 2013 | 2510 | 0.160 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2014 | 4013 | 0.140 |
Why?
|
Healthcare Disparities | 1 | 2012 | 3352 | 0.140 |
Why?
|
Terminology as Topic | 2 | 2014 | 1528 | 0.140 |
Why?
|
Androgen Antagonists | 1 | 2024 | 1408 | 0.120 |
Why?
|
Interviews as Topic | 3 | 2010 | 2696 | 0.110 |
Why?
|
Pneumonia, Aspiration | 2 | 2004 | 145 | 0.110 |
Why?
|
Urogenital System | 1 | 2013 | 88 | 0.110 |
Why?
|
Melanoma | 2 | 2002 | 5694 | 0.100 |
Why?
|
Patient Satisfaction | 2 | 2002 | 3450 | 0.100 |
Why?
|
Comprehension | 2 | 2014 | 619 | 0.090 |
Why?
|
Quality of Life | 4 | 2010 | 13362 | 0.090 |
Why?
|
Insulin Resistance | 1 | 2024 | 3951 | 0.090 |
Why?
|
Marital Status | 1 | 2010 | 425 | 0.080 |
Why?
|
Southeastern United States | 1 | 2008 | 91 | 0.080 |
Why?
|
Health Education | 1 | 2014 | 1049 | 0.070 |
Why?
|
Friends | 1 | 2008 | 148 | 0.070 |
Why?
|
Sickness Impact Profile | 1 | 2008 | 299 | 0.070 |
Why?
|
Socioeconomic Factors | 3 | 2013 | 7804 | 0.070 |
Why?
|
Breast Neoplasms | 2 | 2010 | 20981 | 0.070 |
Why?
|
Prostate | 1 | 2014 | 1772 | 0.070 |
Why?
|
Spouses | 1 | 2008 | 284 | 0.060 |
Why?
|
Poverty | 2 | 2014 | 2692 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2001 | 13630 | 0.060 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2008 | 360 | 0.060 |
Why?
|
Physical Examination | 1 | 2010 | 1255 | 0.060 |
Why?
|
Postoperative Care | 1 | 2010 | 1469 | 0.060 |
Why?
|
Mammography | 2 | 2010 | 2430 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2002 | 3512 | 0.050 |
Why?
|
Aged, 80 and over | 6 | 2009 | 58946 | 0.050 |
Why?
|
Patient Preference | 1 | 2010 | 926 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2002 | 5809 | 0.050 |
Why?
|
Spirituality | 1 | 2007 | 429 | 0.050 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 2023 | 276 | 0.050 |
Why?
|
Aged | 9 | 2024 | 169266 | 0.050 |
Why?
|
Professional-Patient Relations | 1 | 2007 | 722 | 0.050 |
Why?
|
Recombinant Proteins | 2 | 2002 | 6507 | 0.050 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1994 | 2223 | 0.050 |
Why?
|
Neoplasms | 1 | 2010 | 22125 | 0.050 |
Why?
|
Middle Aged | 10 | 2024 | 220835 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2001 | 9278 | 0.040 |
Why?
|
Diagnostic Tests, Routine | 1 | 2005 | 787 | 0.040 |
Why?
|
Male | 11 | 2024 | 360675 | 0.040 |
Why?
|
Humans | 17 | 2024 | 761098 | 0.040 |
Why?
|
BRCA2 Protein | 1 | 2023 | 797 | 0.040 |
Why?
|
Health Status | 1 | 2010 | 4077 | 0.030 |
Why?
|
BRCA1 Protein | 1 | 2023 | 1149 | 0.030 |
Why?
|
Qualitative Research | 1 | 2007 | 3016 | 0.030 |
Why?
|
Prostatectomy | 1 | 2024 | 1825 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2010 | 11118 | 0.030 |
Why?
|
Body Composition | 1 | 2024 | 2427 | 0.030 |
Why?
|
Multimedia | 1 | 2014 | 75 | 0.030 |
Why?
|
Administration, Intravesical | 1 | 1994 | 91 | 0.030 |
Why?
|
Hospital Mortality | 2 | 2004 | 5296 | 0.030 |
Why?
|
Decision Making | 1 | 2007 | 3925 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2010 | 5427 | 0.030 |
Why?
|
Attitude to Health | 1 | 2001 | 2024 | 0.020 |
Why?
|
Patient Discharge | 1 | 2004 | 3441 | 0.020 |
Why?
|
Survival Rate | 2 | 2005 | 12727 | 0.020 |
Why?
|
Interior Design and Furnishings | 1 | 2010 | 34 | 0.020 |
Why?
|
Adult | 5 | 2010 | 221083 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2001 | 6817 | 0.020 |
Why?
|
California | 2 | 2004 | 1431 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2024 | 4947 | 0.020 |
Why?
|
Liver | 1 | 2024 | 7513 | 0.020 |
Why?
|
Female | 6 | 2010 | 392458 | 0.020 |
Why?
|
Comorbidity | 3 | 2005 | 10514 | 0.020 |
Why?
|
Urban Population | 1 | 2013 | 2035 | 0.020 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2004 | 109 | 0.010 |
Why?
|
Radiotherapy | 1 | 2010 | 1498 | 0.010 |
Why?
|
United States | 1 | 2010 | 72337 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2005 | 13382 | 0.010 |
Why?
|
Risk Factors | 2 | 2001 | 74219 | 0.010 |
Why?
|
Risk Adjustment | 1 | 2004 | 601 | 0.010 |
Why?
|
Prospective Studies | 1 | 2024 | 54419 | 0.010 |
Why?
|
Health Personnel | 1 | 2010 | 3335 | 0.010 |
Why?
|
Patient Admission | 1 | 2004 | 1365 | 0.010 |
Why?
|
Anemia | 1 | 2004 | 1504 | 0.010 |
Why?
|
Cause of Death | 1 | 2004 | 3688 | 0.010 |
Why?
|
Odds Ratio | 1 | 2004 | 9648 | 0.010 |
Why?
|
Logistic Models | 1 | 2004 | 13254 | 0.010 |
Why?
|
Models, Statistical | 1 | 2004 | 5077 | 0.010 |
Why?
|
Prevalence | 1 | 2005 | 15717 | 0.000 |
Why?
|
Age Factors | 1 | 2004 | 18385 | 0.000 |
Why?
|
Child | 2 | 2004 | 80134 | 0.000 |
Why?
|
Hospitalization | 1 | 2004 | 10712 | 0.000 |
Why?
|
Risk Assessment | 1 | 2005 | 24013 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2005 | 80673 | 0.000 |
Why?
|
Adolescent | 1 | 2004 | 88271 | 0.000 |
Why?
|